Aging-associated alteration of subtelomeric methylation in Parkinson's disease

49Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A telomere is a repetitive DNA structure capping the chromosomal ends. Telomeres stabilize the chromosome structure and prevent harmful end-to-end recombinations. The telomere length of somatic cells can be determined as the terminal restriction fragment length provided by a genomic Southern blotting analysis, and the telomere length becomes shorter at each mitotic cycle due to an "end-replication problem." Therefore, older somatic cells, which have undergone more mitotic cycles, bear shorter telomeres. This telomere shortening is accelerated by various disease conditions. Parkinson's disease (PD) also yields telomere fragility, thus accelerating the telomere shortening of the circulating leukocytes. This study found that peripheral leukocytes of Japanese PD patients bear fewer short telomeres with constant subtelomeric methylation status in comparison with the healthy controls with increasing short telomeres and also increasing hypomethylated subtelomeres in short telomeres with aging. The correlation between the telomeric attrition and the subtelomeric methylated state in PD is herein discussed. © The Author 2009. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Maeda, T., Guan, J. Z., Oyama, J. I., Higuchi, Y., & Makino, N. (2009). Aging-associated alteration of subtelomeric methylation in Parkinson’s disease. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 64(9), 949–955. https://doi.org/10.1093/gerona/glp070

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free